25 of the Best Hematologist Oncologists Near Me

Britni Mashni is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. Dr. Mashni is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and Triple-Negative Breast Cancer. Dr. Mashni is board certified in American Board Of Internal Medicine. Dr. Mashni is currently accepting new patients.

Shiva Kumar R. Mukkamalla, MD, MPH, specializes in hematology oncology and is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center - Punxsutawney Area Hospital and IRMC Cancer Center in Partnership with UPMC Hillman Cancer Center. Dr. Mukkamalla completed his medical degree at Osmania Medical College, residency at Queens Hospital Center, and fellowship at Roger Williams Medical Center. Dr. Mukkamalla is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Lynch Syndrome, Follicular Lymphoma, Breast Cancer, and Idiopathic Neutropenia. Dr. Mukkamalla is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Mukkamalla is currently accepting new patients.

Rand Naddouje, MD, a hematologist and medical oncologist at Endeavor Health, provides personalized care for patients with cancer and blood disorders. She uses the most current treatments and innovations in oncology to support each individual’s care journey. Dr. Naddouje approaches every patient with compassion and strives to deliver care the way she would want it delivered to herself or a loved one. Dr. Naffouje is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Deep Vein Thrombosis, and Pulmonary Embolism. Dr. Naffouje is board certified in American Board Of Internal Medicine. Dr. Naffouje is currently accepting new patients.

Yen Cao, MD, is a fellowship-trained hematologist and medicaloncologist. She has a research background in Phase I trials andgenitourinary oncology, and a clinical interest in genitourinaryoncology and classical hematology.Dr. Cao’s approach to care is founded on compassion, empathyand commitment to her patients. Through her education andresearch, she strives to provide the highest standard of care,staying abreast of the latest advancements in the field. Shefosters open and honest communication to inform patients andalign treatments with their wellness goals. Dr. Cao believes inworking closely with patients, their families and a multidisciplinaryteam to develop comprehensive and personalized approaches topatient care.Dr. Cao is a member of the American Society of ClinicalOncology, American Society of Hematology and American Collegeof Physicians.Away from work, Dr. Cao enjoys spending time with her husbandand two young children, hiking, tennis, ultimate Frisbee, travelingand cooking. Dr. Cao is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Thrombocytopenia, Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), and Hemangioma Thrombocytopenia Syndrome. Dr. Cao is board certified in Internal Medicine, American Board Of Internal Medicine and Board Eligible In Hematology & Oncology, American Board Of Internal Medicine. Dr. Cao is currently accepting new patients.

Shanker Polsani, M.D., earned his medical degree from Kakatiya Medical College in India. He completed his residency at Louis A. Weiss Memorial Hospital followed by fellowship in Medical Oncology and Hematology at Brody School of Medicine at East Carolina University. He is board certified in Internal Medicine, Medical Oncology and Hematology.Prior to joining Piedmont, Dr. Polsani was Chief Fellow of Hematology and Medical Oncology at Brody School of Medicine and has worked as an Assistant Professor in the Section of Hospital Medicine at Wake Forest Baptist Medical Center in Winston Salem, NC.Dr. Polsani specializes in Medical Oncology and Hematology. Dr. Polsani has a special interest in GI, Thoracic Oncology and Classical Hematology.In his spare time, Dr. Polsani enjoys spending time with his family and friends. He enjoys playing tennis. Dr. Polsani is accepting new patients and welcomes most major insurance plans. Dr. Polsani is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Anemia, Thrombocytopenia, and Febrile Neutropenia. Dr. Polsani is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine. Dr. Polsani is currently accepting new patients.

Neil Shah is a Hematologist Oncology provider practicing medicine in San Francisco, California. Dr. Shah is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Childhood Acute Myeloid Leukemia, and Polycythemia Vera. Dr. Shah is board certified in American Board Of Internal Medicine/Hematology, Hematology. Dr. Shah is currently accepting new patients.

Charise Gleason is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. Dr. Gleason is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant. Dr. Gleason is board certified in Oncology Nursing Certification Corporation.

Jocelin Huang is a Hematologist and an Oncologist practicing medicine in Edina, Minnesota. Dr. Huang is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Diffuse Large B-Cell Lymphoma (DLBCL). Dr. Huang is board certified in Medical Oncology: American Board Of Internal Medicine, 2012 and Hematology: American Board Of Internal Medicine, 2012. Dr. Huang is currently accepting new patients.

Aimee Merino is a Hematologist Oncology specialist and a Hematologist practicing medicine in Minneapolis, Minnesota. Dr. Merino is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Merino is board certified in Medical Oncology: American Board Of Internal Medicine, 2023, Hematology: American Board Of Internal Medicine, 2021, and Internal Medicine: American Board Of Internal Medicine, 2018. Dr. Merino is currently accepting new patients.

Alex Nester is a Hematologist and an Oncologist practicing medicine in Omaha, Nebraska. Dr. Nester is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Virus Associated Hemophagocytic Syndrome, Hemophagocytic Lymphohistiocytosis, Hemophilia B, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Nester is currently accepting new patients.

Dr. Ashley Hanlon is a specialty care physician board certified in hematology and oncology and internal medicine. She joined Inova Health System in 2021 and has been practicing since 2014. Prior to joining Inova, Dr. Hanlon completed her hematology and oncology fellowship at Duke University in Durham, NC. Memberships/Accreditations Associate Member, American Society of Hematology Associate Member, American Society of Clinical Oncology Member, American College of Physicians. Dr. Hanlon is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and POEMS Syndrome. Dr. Hanlon is currently accepting new patients.

Dr. Hua-Jay “Jeff” Cherng is an assistant professor of medicine in the lymphoma program in the Division of Hematology and Oncology. He earned his medical degree from Case Western Reserve University and completed internal medicine residency at the Hospital of the University of Pennsylvania. He subsequently trained at MD Anderson Cancer Center for his hematology and oncology fellowship. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Cherng is a clinical investigator who researches non-invasive response assessment tools such as biomarkers and imaging to predict outcomes of lymphoma patients. His focus is on circulating tumor DNA (ctDNA), fragments of genetic material shed by lymphomas that can be sequenced and tracked to measure molecular response and minimal residual disease. His work on ctDNA and PET scans in lymphoma has led to publications in high-impact journals including Blood, Blood Advances, American Journal of Hematology, and British Journal of Haematology. He has earned abstract merit awards from the American Society of Hematology, American Society of Clinical Oncology, and Pan Pacific Lymphoma Conference. His accomplishments during fellowship earned him a Waun Ki Hong Award for Achievement in Clinical Investigation. He has participated in the Academy of Next Wave of Investigators for non-Hodgkin’s lymphoma and the American Society of Hematology Clinical Research Training Institute. His research on ctDNA has been funded by a Conquer Cancer Young Investigator Award and Career Development Award as well as a NIH/NCI R03 Small Research Grant. He is a member of the SWOG Lymphoma Working Group and Committee. Dr. Cherng’s designs clinical trials with treatment guided by ctDNA; this would allow for treatment de-escalation in good responders to minimize toxicity and escalation in poor responders to maximize chance for durable remissions. Dr. Cherng sees patients with all types of lymphoma with an emphasis on aggressive non-Hodgkin B-cell lymphomas. He treats patients with standard-of-care treatments as well as on clinical trial protocols. Dr. Cherng is highly rated in 3 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), and Bone Marrow Transplant. Dr. Cherng is currently accepting new patients.

Dr. Richard Van Etten is a board-certified, fellowship-trained UCI Health hematologist and oncologist who specializes in the treatment of leukemia and other blood cancers. His clinical focus also includes hematopoetic stem cell transplant services.He is the director of the Chao Family Comprehensive Cancer Center, where he leads a team of more than 250 physicians, basic and translational scientists conducting cancer research at UC Irvine.Van Etten received a medical degree and a PhD in biophysics from the Stanford University School of Medicine, where he worked with biochemist David F. Clayton, PhD, on the molecular genetics of mammalian mitochondrial DNA and brain development. He went on to complete a residency in internal medicine and a fellowship in hematology at Harvard School of Medicine and Brigham & Women's Hospital in Boston. Next he worked as a visiting scientist in the lab of Nobel laureate David Baltimore at the Massachusetts Institute of Technology's Whitehead Institute in Boston.He joined the Harvard Medical School and Brigham & Women's Hospital as a faculty member of the departments of Medicine and Genetics. In 2003, he became a professor of Medicine at Tufts Medical Center and director of the Hematologic Malignancies Program at Tufts Cancer Center, eventually becoming chief of the Division of Hematology/Oncology. In 2009, he was named director of the Tufts Cancer Center.Van Etten became director of the Chao Family Comprehensive Cancer Center on Oct. 1, 2013 and a professor of Medicine and Biochemistry in the UCI School of Medicine. Under his leadership, the cancer center's comprehensive cancer center designation has been renewed twice by the National Cancer Institute. He is the author of more than 150 scientific articles, reviews and book chapters. His research lab, which is funded by grants from the National Cancer Institute, investigates the molecular pathogenesis of leukemia and myeloproliferative neoplasms with an emphasis on dysregulated tyrosine kinases and mouse model systems.Nickname: Rick. Dr. Van Etten is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Childhood Acute Myeloid Leukemia, Multicentric Castleman Disease (MCD), and Bone Marrow Aspiration. Dr. Van Etten is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine - Internal Medicine.

Teena Bhatla is a Hematologist and an Oncologist practicing medicine in Newark, New Jersey. Dr. Bhatla is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Fibrosarcoma, and Burkitt Lymphoma. Dr. Bhatla is currently accepting new patients.

Peihong Hsu is an Oncologist and a Hematologist practicing medicine in New Hyde Park, New York. She has been practicing medicine for over 44 years. Dr. Hsu is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Lymphofollicular Hyperplasia, Leukocytosis, Non-Hodgkin Lymphoma, and Small Lymphocytic Lymphoma (SLL). Dr. Hsu is board certified in American Board Of Pathology/Hematology and American Board Of Pathology/Anatomic & Clinical.

Rene Ashworth is a Hematologist and an Oncologist practicing medicine in Manhasset, New York. Dr. Ashworth is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Gamma Knife Radiosurgery, and Pancreatectomy. Dr. Ashworth is board certified in American Board Of Internal Medicine/Medical Oncology and American Board Of Internal Medicine.

Jean Wadman is a Hematologist and an Oncologist practicing medicine in Wilmington, Delaware. Dr. Wadman is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobin SC Disease, Hemoglobinopathy, and Hemoglobin E Disease. Dr. Wadman is board certified in Pediatric Nursing Certification Board. Dr. Wadman is currently accepting new patients.

Frederick Howard is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Howard is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Hemophagocytic Lymphohistiocytosis. Dr. Howard is board certified in Hematology Internal Medicine Medical Oncology.

Robb Friedman is a Hematologist and an Oncologist practicing medicine in Newton, Massachusetts. Dr. Friedman is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Thalassemia, Essential Thrombocythemia, Myelodysplastic Syndrome (MDS), and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Friedman is currently accepting new patients.

Vinod Parameswaran is a Hematologist and an Oncologist practicing medicine in Sioux Falls, South Dakota. Dr. Parameswaran is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Multiple Myeloma, Thrombocytopenia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Parameswaran is currently accepting new patients.

John Huber is a Hematologist and an Oncologist practicing medicine in Louisville, Kentucky. Dr. Huber is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Chronic Lymphocytic Leukemia (CLL), Thrombocytopenia, and Bone Marrow Aspiration. Dr. Huber is currently accepting new patients.

Luis Chu is a Hematologist and an Oncologist practicing medicine in Sarasota, Florida. Dr. Chu is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Paget Disease of the Breast, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Chu is board certified in American Board Of Internal Medicine. Dr. Chu is currently accepting new patients.

Sanjay Hapani is a Hematologist and an Oncologist practicing medicine in Oklahoma City, Oklahoma. Dr. Hapani is highly rated in 52 conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Familial Colorectal Cancer, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration. Dr. Hapani is currently accepting new patients.

Akash Patnaik is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Patnaik is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, and Prostatectomy. Dr. Patnaik is board certified in Practicing Since2006 and Medical Oncology. Dr. Patnaik is currently accepting new patients.

Dr. Katherine Antel earned her medical degree from the University of Cape Town, South Africa and where she went on to complete an internal medicine residency and a fellowship in hematology and bone marrow transplant. Dr. Antel went on to pursue 3-year research fellowship in lymphoid genomics at the Dana-Farber Cancer Institute, Boston U.S. Her research area of interest is in lymphoid biology, and lymphoid genomics. Dr. Antel is an associate professor at the Medical University of South Carolina in Charleston. Her clinical and research areas of interest include the biology and genomics of aggressive lymphoma and the development of clinical assays to detect and diagnose lymphoma using cell-free DNA. Dr. Antel is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Lymphofollicular Hyperplasia, Lymphadenitis, Hodgkin Lymphoma, and Burkitt Lymphoma. Dr. Antel is currently accepting new patients.